Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups. A longitudinal study FRONTIERS IN IMMUNOLOGY 2022
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma PATHOGENS 2022
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies Social Science Research Network 2022
Quality of T-Cell Response to SARS-CoV-2 mRNA Vaccine in ART-Treated PLWH INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study LE INFEZIONI IN MEDICINA 2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study INFECTION 2022
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w) INFECTION 2022
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) VIRUS RESEARCH 2021
Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? THE JOURNAL OF HOSPITAL INFECTION 2021
Face Mask Use in the Community for Reducing the Spread of COVID-19: A Systematic Review FRONTIERS IN MEDICINE 2021
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study FRONTIERS IN NUTRITION 2021
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 2021
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study FRONTIERS IN NUTRITION 2021
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report THROMBOSIS AND HAEMOSTASIS 2021
Does Lung Ultrasound Have a Role in the Clinical Management of Pregnant Women with SARS COV2 Infection? INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection CHEMOTHERAPY 2021
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic INTERNAL AND EMERGENCY MEDICINE 2021
Molecular Identification of New Cases of Human Dirofilariosis (Dirofilaria repens) in Italy PATHOGENS 2021

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma